Cabot Corporation (NYSE:CBT) Given Consensus Rating of “Reduce” by Brokerages

Cabot Corporation (NYSE:CBT) has been assigned a consensus rating of “Reduce” from the five research firms that are presently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating and one has assigned a buy rating to the company. The average 1-year price target among brokers that have issued a report on the stock in the last year is $79.3333.

CBT has been the subject of a number of research analyst reports. UBS Group decreased their price objective on shares of Cabot from $82.00 to $65.00 and set a “neutral” rating for the company in a report on Wednesday, November 5th. Zacks Research lowered shares of Cabot from a “hold” rating to a “strong sell” rating in a report on Friday. Mizuho reduced their price target on Cabot from $90.00 to $88.00 and set an “outperform” rating on the stock in a report on Friday, October 3rd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Wednesday, October 8th.

Insiders Place Their Bets

In other news, CEO Sean D. Keohane sold 114,436 shares of the stock in a transaction on Thursday, August 14th. The stock was sold at an average price of $79.28, for a total transaction of $9,072,486.08. Following the transaction, the chief executive officer directly owned 361,518 shares of the company’s stock, valued at $28,661,147.04. This represents a 24.04% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 3.03% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently added to or reduced their stakes in CBT. EverSource Wealth Advisors LLC raised its stake in Cabot by 51.5% during the third quarter. EverSource Wealth Advisors LLC now owns 1,232 shares of the specialty chemicals company’s stock valued at $94,000 after purchasing an additional 419 shares in the last quarter. State of New Jersey Common Pension Fund D lifted its holdings in Cabot by 5.7% during the third quarter. State of New Jersey Common Pension Fund D now owns 26,891 shares of the specialty chemicals company’s stock worth $2,045,000 after buying an additional 1,456 shares during the period. PNC Financial Services Group Inc. boosted its holdings in shares of Cabot by 62.7% in the 3rd quarter. PNC Financial Services Group Inc. now owns 4,524 shares of the specialty chemicals company’s stock valued at $344,000 after buying an additional 1,744 shares in the last quarter. Assetmark Inc. grew its stake in Cabot by 13.0% during the 3rd quarter. Assetmark Inc. now owns 7,123 shares of the specialty chemicals company’s stock worth $542,000 after buying an additional 821 shares during the last quarter. Finally, MQS Management LLC acquired a new position in Cabot during the 3rd quarter valued at approximately $369,000. 93.18% of the stock is owned by hedge funds and other institutional investors.

Cabot Stock Performance

Shares of Cabot stock opened at $61.16 on Tuesday. The company’s fifty day moving average is $73.04 and its 200 day moving average is $75.37. The company has a quick ratio of 1.41, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. The stock has a market cap of $3.25 billion, a price-to-earnings ratio of 7.99 and a beta of 0.90. Cabot has a twelve month low of $58.99 and a twelve month high of $117.25.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, November 3rd. The specialty chemicals company reported $1.70 EPS for the quarter, missing analysts’ consensus estimates of $1.72 by ($0.02). Cabot had a net margin of 11.14% and a return on equity of 25.68%. The firm had revenue of $899.00 million for the quarter, compared to the consensus estimate of $967.02 million. During the same period last year, the company posted $1.80 EPS. The business’s revenue was down 10.2% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-7.00 EPS. Sell-side analysts forecast that Cabot will post 7.57 EPS for the current year.

About Cabot

Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.